Tyrosine kinase inhibitor‐induced IL‐6/STAT3 activation decreases sensitivity of EGFR‐mutant non‐small cell lung cancer to icotinibJinyao Wang, Xiaofang Che, Chunlei Zheng et al.|Cell Biology International|2018Cited by 21